Page last updated: 2024-08-16

thalidomide and sildenafil citrate

thalidomide has been researched along with sildenafil citrate in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Barreiro, EJ; Cadete, RA; Ferreira, HC; Figueira, RC; Koatz, VL; Légora-Machado, A; Lima, LM; Momesso, DP; Rocco, PR; Zin, WA	1
Bajwah, S; Higginson, IJ; Koffman, J; Patel, AS; Peacock, JL; Riley, J; Ross, JR; Wells, AU	1
Trenor, CC	1
Atanaskova Mesinkovska, N; Juhász, MLW	1

Reviews

3 review(s) available for thalidomide and sildenafil citrate

Article	Year
Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature. Thorax, 2013, Volume: 68, Issue:9 Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Cough; Dyspnea; Exercise Test; Fibrosis; Glucocorticoids; Heroin; Humans; Immunologic Factors; Lung; Lung Diseases, Interstitial; Narcotics; Oxygen Inhalation Therapy; Piperazines; Prednisolone; Purines; Pyridones; Quality of Life; Sildenafil Citrate; Sulfones; Thalidomide; Tubulin Modulators	2013
Medical management of vascular anomalies. Seminars in cutaneous medicine and surgery, 2016, Volume: 35, Issue:3 Topics: Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Bevacizumab; Clinical Decision-Making; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Interferons; Propranolol; Sildenafil Citrate; Sirolimus; Thalidomide; Vascular Malformations	2016
The use of phosphodiesterase inhibitors for the treatment of alopecia. The Journal of dermatological treatment, 2020, Volume: 31, Issue:3 Topics: Alopecia; Caffeine; Cicatrix; Clinical Trials as Topic; Humans; Phosphodiesterase Inhibitors; Sildenafil Citrate; Thalidomide	2020

Trials

1 trial(s) available for thalidomide and sildenafil citrate

Article	Year
Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injury. The European respiratory journal, 2003, Volume: 22, Issue:1 Topics: Analysis of Variance; Animals; Bronchoalveolar Lavage Fluid; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Neutrophils; Phosphodiesterase Inhibitors; Piperazines; Purines; Respiratory Distress Syndrome; Respiratory Function Tests; Respiratory Mechanics; Sildenafil Citrate; Statistics, Nonparametric; Sulfones; Thalidomide; Tumor Necrosis Factor-alpha	2003

Article

Year

Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injury.

The European respiratory journal, 2003, Volume: 22, Issue:1

Topics: Analysis of Variance; Animals; Bronchoalveolar Lavage Fluid; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Neutrophils; Phosphodiesterase Inhibitors; Piperazines; Purines; Respiratory Distress Syndrome; Respiratory Function Tests; Respiratory Mechanics; Sildenafil Citrate; Statistics, Nonparametric; Sulfones; Thalidomide; Tumor Necrosis Factor-alpha

2003